Aurora-A, a serine/threonine kinase located at the centrosome, is overexpressed in 10-60% of breast cancers [29], functions as a pro-survival protein that promotes tumor cell proliferation, counteracts apoptosis and induces drug resistance in tumor cells [29,34]. The gene discussed is MARK2; the disease is neoplasm.